Quarterly Result25 Feb 2026, 08:32 pm
Sanofi Consumer Healthcare India Ltd Reports Q4’25 Revenue at 2,510 MN, Up by 47%, Net Profit at 665 MN, Up by 50%
AI Summary
Sanofi Consumer Healthcare India Ltd has reported its financial results for the fourth quarter, demonstrating sustained growth momentum across key business segments. The company's revenue growth for the quarter stood at 47% year-on-year, with domestic sales growing by 23% and profit after tax (PAT) reaching 3665 million, an increase of 50% on a year-on-year basis. For the full year 2025, the Company reported revenue of 8,784 million, reflecting a growth of 21% over the previous year. Profit after tax for the year stood at 2,401 million, up 33% year-on-year. A dividend of 75 per share was also declared for the year ended December 31,2025.
Key Highlights
- Revenue at 32,510 million, a growth of 47%
- Domestic Sales grew by 23%
- Export Sales grew by 9.3x
- Profit After Tax was up by 50%
- Full-year revenue of 8,784 million, up by 21%
- Full-year profit after tax up by 33%
- Dividend of 75 per share declared